MeSH tree: D12.644.548
New research has found that a hormone is responsible for making mothers' interactions with newborns feel rewarding rather than just necessary. The University of Otago—Ōtākou Whakaihu Waka study, published in Science Advances, ...
Jul 23, 2026
0
7
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ finds. ...
Jul 22, 2026
0
25
Anyone who has bought medicine online may have wondered whether what arrived in the mail was really what they had paid for. They are not alone. A recent global survey found that around 60% of people fear their medicines could ...
Jul 22, 2026
0
3
Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains strong—and some patients may unknowingly be receiving products from pharmacies with concerning ...
Jul 17, 2026
0
6
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds ...
Jul 16, 2026
0
5
Public interest in obesity medication has risen 25-fold since the launch of GLP-1 receptor agonist drugs, new research presented at the International Congress on Obesity (ICO2026) in Mexico City, Mexico, hosted by the World ...
Jul 15, 2026
0
21
For generations, early to bed and early to rise was seen as the blueprint for a healthy life, and any departure from it was often considered unhealthy. Scientists, however, have discovered that whether someone is an early ...
For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after ...
Jul 10, 2026
0
6
People with anorexia nervosa have unusually high levels of a hormone called LEAP2 in their blood when they are in the acute phase of the disorder, according to research presented at the Federation of European Neuroscience ...
Jul 9, 2026
0
4
About 1 in 5 women will experience depression and anxiety during pregnancy or in the year after giving birth. If untreated, a mother who has these conditions has a higher risk of birth complications, poorer overall health, ...
Jul 7, 2026
0
3
